Definitive Healthcare announced the appointment of Tina Hannagan as its Chief Commercial Officer, effective June 1, 2025. This key executive hire is part of the company's strategic efforts to strengthen its commercial leadership and drive market performance.
Ms. Hannagan received an inducement award consisting of 830,565 time-based restricted stock units (RSUs). These RSUs will vest over approximately four years, with 25% vesting on June 1, 2026, and the remainder in quarterly installments.
The Chief Commercial Officer role is crucial for overseeing the company's commercial strategy, sales, and customer engagement initiatives. This appointment is expected to play a vital role in executing Definitive Healthcare's operational reset and achieving future growth objectives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.